Wisconsin Republicans Unveil Plan To Legalize Non-Smokable Medical Marijuana With State-Run Dispensaries

Wisconsin Republicans have unveiled a plan to legalize non-smokable medical marijuana through state-run dispensaries staffed by government-employed pharmacists, with a limited set of conditions that could qualify patients for the program.

At a series of press conferences across the state on Monday, GOP state lawmakers detailed the much-anticipated legislation, which would make Wisconsin the “first state to have state-run dispensaries,” operated by the Department of Health Services (DHS).

As expected, the proposal would create a restrictive system that limits patients to smokeless cannabis options such as oils and gummies. People with qualifying conditions would be eligible to receive a doctor’s recommendation and access the products, which would be sold at five dispensaries across the state.

“We’ve come up with a program I think is going to be very beneficial to a lot of Wisconsinites,” Rep. Jon Plumer (R) said, while acknowledging that the state-controlled dispensaries component is a key area “where our program is different” than other medical marijuana states.

The qualifying conditions include cancer, epilepsy, post-traumatic stress disorder (PTSD), glaucoma, severe chronic pain, muscle spasms, chronic nausea, multiple sclerosis, inflammatory bowel disease, Alzheimer’s disease and terminal illness with less than one year life expectancy.

While the dispensaries would be state-run, growers and processors would be independently operated if they obtain a permit from the state. The pharmacists who dispense the cannabis to patients would be “state employees,” Plumer said.

“We think we have a good program put together. It’s going to be probably modified over the years as we learn about it—as we realize we have changes we should probably make,” he said. “But I think we’re at a really strong starting point here.”

Rep. Tony Kurtz (R) said the proposal underscores how Republicans are “leading to have a great opportunity to introduce a much-needed program with medical cannabis with controls.”

Keep reading

New Colorado Marijuana Hospitality Rules Take Effect As Regulators Tout Earlier ‘Successes’ Like Online Sales

Colorado marijuana regulators are promoting new rules for the industry that take effect on Monday—including increased sales limits for cannabis hospitality businesses that allow on-site use. They are also touting “successes” from the past year such as opening up online sales.

The state Marijuana Enforcement Division (MED) shared a list of rules that have been enacted under legislation passed by lawmakers and signed into law by Gov. Jared Polis (D) last year.

At the top of the list is the online sales development, which took effect last August. Customers must still physically pick up the marijuana products from retailers, but now they can browse and electronically purchase cannabis online ahead of visiting the store.

As of January 8, other key regulations are being implemented, too. That includes increasing the amount of cannabis that can be sold at licensed marijuana hospitality businesses to one ounce of flower and eight grams of concentrate.

The new rules will also require hospitality businesses to provide patrons with information about transportation options and establish standards to prevent overconsumption, while exempting them from certain requirements related to video surveillance at certain areas of spas.

Regulations that have already taken effect this past year that MED highlighted include new authorizations to seize and destroy regulated marijuana products that pose a threat to public health, a rule that allows new cannabis businesses to maintain and renew state licensure even if they’re rejected by local governments and empowering regulators to promulgate rules allowing or banning “chemical modification, conversion, or synthetic derivation of cannabinoids.”

“As we approach the new year, we are committed to leveraging the unique opportunity we have to reflect on our successes and lessons learned as one of the most mature adult-use cannabis markets in the nation,” Dominique Mendiola, senior director of MED, said in a press release. “We look forward to continuing our work together to demonstrate a model for responsible regulation as directed by the voters of Colorado and the General Assembly.”

The regulatory update comes days after Colorado’s governor, advocates and stakeholders celebrated the 10th anniversary of the first legal cannabis sales nationally and globally in the state.

Keep reading

DeSantis Says He Would ‘Respect The Decisions That States Make’ On Marijuana Legalization, Despite Personal Opposition

Florida Gov. Ron DeSantis (R) says he would “respect the decisions that states make” on marijuana legalization if he’s elected president, despite his personal view that the reform has a “negative impact.”

At a campaign event in Iowa on Saturday, the 2024 Republican presidential candidate briefly shared how he would navigate the growing state legalization movement from the White House, pledging to adopt a hands-off approach like that of prior administrations from both parties.

DeSantis started by noting that Florida voters enacted medical cannabis legalization as a constitutional amendment at the ballot, and then he criticized what he views as shortcomings of broader adult-use legalization before explaining how he’d address it as president.

“I think the places that have done it for recreational use like Colorado, I don’t think it’s worked well,” he said in comments first noted by Florida Politics. “I think it’s caused problems in the cities. I think it’s created a black market.”

“We’ll respect the decisions that the states make on that,” the governor said. “But I do think some of these places like California and Colorado—I don’t know what they did with it, but, I mean, it has definitely caused a negative impact on their workforce.”

Colorado has been a frequent target of DeSantis’s criticism, with the candidate also claiming recently that the state’s illicit cannabis market is “bigger” today than it was prior to voters approving legalization in 2012.

Colorado Gov. Jared Polis’s (D) office pushed back against that position in a statement to Marijuana Moment last week, asserting that the reform is “curbing the illicit market, getting dealers off the streets, reducing youth use, funding school construction, supporting jobs and Colorado’s economy.”

“Colorado is happy to provide the Florida governor advice on how to increase economic and personal freedom like we have in the free state of Colorado,” a spokesperson said.

Keep reading

Psychedelic Drugs Are Rushing Towards Approval for Therapy. Here’s What’s Next

Psychedelics made their mark this year—not as counterculture party drugs, but as a new paradigm in mental health therapy.

In June, Australia became the first country to greenlight MDMA, popularly known as molly or ecstasy, and psilocybin, the active ingredient in magic mushrooms, to treat post-traumatic stress disorder (PTSD) and depression.

MDMA also inched closer to approval in the US for PTSD, thanks to positive results from a large multi-site, double-blind, randomized trial—the gold standard for testing drug safety and efficacy.

Meanwhile, psilocybin gained steam as a treatment for severe depression. A randomized, placebo-controlled trial in 104 adults found that a single dose of magic mushrooms dampened the symptoms of depression when combined with psychological support. The effects lasted at least six weeks with minimal side effects. Clinical trials are in the works to explore whether psilocybin and its derivatives can help patients cope with chronic lower back pain, tackle depression in bipolar disorder, and ease mental struggles in end-of-life care.

This year also saw magic mushrooms for therapy move ahead. Registered clinics in Oregon have already begun psilocybin treatments in patients with mental health disorders ranging from obsessive-compulsive disorders to PTSD—even though the drug isn’t federally approved and remains illegal.

In 2022, Oregon became the first state to legalize psilocybin therapy with strict regulations: The mushrooms are carefully controlled for potency and quality and need to be taken under supervision. The guidelines offer a blueprint for other states—such as Colorado, which also decriminalized psilocybin for potential therapeutic use.

Yet one glaring problem remains. Despite promising clinical results, no one knows exactly how psychedelic drugs work in the brain. Examining their actions on brain cells isn’t just an academic curiosity. It could give rise to variants that maintain antidepressant properties without the high. And because hallucinogens substantially alter our perception of the world, they could be powerful tools for investigating the neurobiology behind consciousness.

Keep reading

Colorado Governor’s Office Slams DeSantis’s Marijuana Stance, Pushing Back Against Claim Legalization Led To ‘Bigger’ Illicit Market

If Florida Gov. Ron DeSantis (R) needs some advice on how to promote “economic and personal freedom,” the state of Colorado is “happy” to explain the advantages of marijuana legalization, Gov. Jared Polis’s (D) office said after the Republican presidential candidate doubled down on his opposition to cannabis reform.

On Friday, DeSantis peddled a dubious claim that Colorado’s illicit market is “bigger” today than it was before legalizing adult-use cannabis in 2012, justifying his own personal opposition to the reform.

In response, a spokesperson for the Colorado governor’s office offered to correct the record for the 2024 GOP presidential hopeful in a statement to Marijuana Moment.

“The facts are that Colorado voters approved the legalization of marijuana which is curbing the illicit market, getting dealers off the streets, reducing youth use, funding school construction, supporting jobs and Colorado’s economy,” the governor’s spokesperson said. “Colorado is happy to provide the Florida governor advice on how to increase economic and personal freedom like we have in the free state of Colorado.”

In an interview on the radio station KCPS that aired on Friday, first noted by Florida Politics, DeSantis had challenged the idea that regulating marijuana sales puts illicit operators “out of business,” stating that it’s an “interesting” concept that he says hasn’t played out in Colorado, despite evidence to the contrary.

“There have been states like Colorado who’ve done things like legalized marijuana and the argument was, well, you want to have a black market? It will be above-board, taxed and all that stuff,” DeSantis said during the interview. “Yet Colorado has a bigger black market of marijuana since they’ve legalized it.”

It’s well-understood that enacting legalization doesn’t fully eliminate the illicit market, and states have had varying degrees of success to that end. But research indicates that Colorado has been among the most effective at transitioning people to the legal marketplace.

Keep reading

Florida GOP Lawmaker Files Bill To Cap Marijuana At 10% THC If Voters Approve Legalization Ballot Measure

Ahead of a potential Florida marijuana legalization vote on the ballot this November, a Republican lawmaker has preemptively filed a bill that would impose strict limitations on THC potency if the reform is approved by voters.

Rep. Ralph Massullo (R) introduced the legislation on Friday, proposing a THC cap that is significantly lower than what’s available in most state markets. It would take effect 30 days after voters pass any future constitutional amendment to enact legalization.

The bill would set a 10 percent THC limit for cannabis products that are meant for smoking and a 60 percent limit for other forms of marijuana such as extracts. Edibles could not contain more than 200 milligrams of THC, and individual servings could only have up to 10 milligrams.

This would create serious logistical and commercial problems for any adult-use market, and it’d likely be met with significant pushback from consumers, advocates and stakeholders if enacted. Cannabis flower that’s sold at the average recreational retailer or medical dispensary typically hovers around 20-30 percent THC.

That’s true of Florida’s existing medical cannabis market, too. And because Massullo’s bill only addresses “potency limits for adult personal use,” the proposal could create further complications by having two different sets of THC rules for patients and consumers.

Florida’s medical cannabis dosage limits—which were revised under controversial rules adopted in 2022, despite pushback from then-Agriculture Commissioner Nikki Fried (D)—are not based on the percentage of THC in a given product.

Keep reading

Kentucky Governor Pushes Lawmakers To Approve More Medical Marijuana Qualifying Conditions While Unveiling First Program Rules

The governor of Kentucky is urging lawmakers to significantly expand the state’s medical marijuana law by adding new qualifying conditions as the administration puts forward a series of initial proposed regulations to begin implementing the program.

At a briefing on Thursday, Gov. Andy Beshear (D) announced that two independent advisory groups he appointed have unanimously voted to recommend that the legislature add more than a dozen new conditions to qualify patients for medical cannabis under a law he signed last year.

“This is a crucial step. While the legislation referenced several qualifying conditions, it left others out,” he said, adding that the expanded list includes “very serious conditions that we believe—but more importantly that these medical groups and advisory groups all unanimously agree—should become a part of the program.”

Keep reading

DEA Confirms That Psychedelic Mushroom Spores Are Federally Legal Prior To Germination

A top Drug Enforcement Administration (DEA) has affirmed that spores that produce so-called magic mushrooms are not, on their own, federally prohibited.

DEA’s Drug & Chemical Evaluation Section Chief Terrence Boos was asked about the legal status of the spores in a letter from attorney Michael McGuire in November, and he sent a response on Tuesday that clarified the agency’s position.

“If the mushroom spores (or any other material) do not contain psilocybin or psilocin (or any other controlled substance or listed chemical), the material is considered not controlled” under the Controlled Substances Act (CSA), Boos wrote.

“However, if at any time the material contains a controlled substance such as psilocybin or psilocin (for example, upon germination), the material would be considered a controlled substance under the CSA,” he said, as Kight On Cannabis first reported.

This isn’t especially revelatory, as its long been understood that the CSA doesn’t explicitly ban spores that can be used to produce so-called “magic mushrooms.” Rather, it lists the key psychoactive ingredients in psychedelic mushrooms, psilocybin and psilocyn, as Schedule I controlled substances.

Because the spores themselves don’t contain those specific compounds, they are uncontrolled under the CSA.

However, it should be noted that while the spores are technically considered federally legal—as long as someone doesn’t use them to produce mushrooms that contain psilocybin or psilocin—states such as California, Georgia and Idaho do prohibit the spores themselves.

Keep reading

New Kentucky Bill Would Legalize Marijuana Use, Possession And Home Cultivation—But Not Sales

As Kentucky works to implement a recently passed medical cannabis policy, a lawmaker filed legislation this week that would end all penalties, including arrest, for simple possession and use of recreational marijuana by adults 21 and older. It would also allow adults to grow a small number of cannabis plants at home for personal use. Commercial sales, however, would remain prohibited.

The limited legalization measure, HB 72, was introduced Tuesday by Rep. Nima Kulkarni (D), who this time last year introduced a measure that would have let voters decide whether to legalize use, possession and home cultivation. The lawmaker previously introduced a similar noncommercial legalization proposal for the 2022 legislative session.

“For decades, the failed and irrational War on Drugs has ensured that we have arrested, prosecuted and jailed millions of Americans for low level nonviolent drug offenses,” Kulkarni said a year ago.

Under the new proposal, adults could possess up to an ounce of marijuana in plant form, five grams of cannabinoids derived from hemp or marijuana, products containing 1,000 milligrams or less of delta-8 and delta-9 THC or five or fewer cannabis plants.

Possession above the personal use limit would be considered a Class B misdemeanor, carrying up to 45 days of jail time plus monetary penalties.

In addition to ending penalties for noncommercial possession and cultivation, the newly filed legislation would also prevent marijuana use from being used as grounds to revoke probation, parole or conditional release.

Trafficking penalties, meanwhile—which state law says someone is guilty of “when he knowingly and unlawfully traffics in marijuana”—would apply to people with more than the personal use quantity and less than eight ounces of cannabis. That would be a Class A misdemeanor on the first offense and a Class D felony on second and subsequent offenses. Higher penalties would apply for greater amounts.

Keep reading

Massachusetts Lawmakers Will Be Forced To Consider Psychedelics Legalization Measure That Activists Petitioned For, State Official Says

Massachusetts officials have certified that activists submitted enough valid signatures to force legislative consideration of a psychedelics legalization initiative before the measure potentially heads to the state’s 2024 ballot.

Secretary of the Commonwealth William Galvin’s (D) office certified that the campaign Massachusetts for Mental Health Options (MMHO) collected 96,277 valid signatures for the reform measure—about 20,000 more than required to put the issue before legislators.

Accordingly, the proposal has now been officially transmitted to the legislature.

“This brings psilocybin and other breakthrough psychedelic therapies one big step closer to being available to adults dealing with depression, anxiety and other mental health challenges,” Jennifer Manley, committee spokesperson, said in a press release on Wednesday.

“We look forward to working with legislative leaders on the possibility and promise of natural psychedelic medicine as we continue our work to provide therapeutic access to these groundbreaking treatments,” she said. “We thank the secretary and his staff for their service reviewing the nearly 100,000 signatures submitted in support, as well as the volunteers and advocates who spent many hours talking to voters around the state.”

The announcement came after a longer-than-usual review process, which was due to an especially high volume of ballot proposals that were being circulated for the 2024 election cycle.

The MMHO measure would create a regulatory framework for lawful and supervised access to psychedelics at licensed facilities. It would also legalize the possession and gifting of psychedelics such as psilocybin and ayahuasca, but it would not otherwise provide for commercial retail sales of the substances.

“We are on the precipice of a sea change in the way we can help people who may believe they have run out of options,” Winthrop police lieutenant Sarko Gergerian, one of the campaign’s backers, said. “Don’t lose hope. These options could be available soon for you and your loved ones here in Massachusetts.”

The campaign first filed two different psychedelics reform initiatives in August, and after the state attorney general determined that they both met the constitutional requirement for ballot placement the following months, activists decided to pursue the version that included a home cultivation option.

Now that the secretary of state has verified the signature count, the legislature will now have the choice to enact the reform, propose a substitute or decline to act. If lawmakers decide not to legalize psychedelics by May 1, activists would then have until July 3 to submit at least 12,429 additional valid signatures to put the proposal before voters on the November 2024 ballot.

Keep reading